Marlow Hernandez - Aug 18, 2021 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role
CEO and President, Director
Signature
/s/ David Armstrong, Attorney-in-Fact for Marlow Hernandez
Stock symbol
CANO
Transactions as of
Aug 18, 2021
Transactions value $
$539,672
Form type
4
Date filed
8/23/2021, 07:00 PM
Previous filing
Aug 23, 2021
Next filing
Aug 31, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Purchase $117K +11.9K +5.67% $9.82* 222K Aug 18, 2021 Direct F1
transaction CANO Class A Common Stock Purchase $260K +25K +11.27% $10.38* 247K Aug 19, 2021 Direct F2
transaction CANO Class A Common Stock Purchase $102K +10K +4.05% $10.20* 257K Aug 20, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CANO Warrants to purchase Class A Common Stock Purchase $4.21K +1.83K +0.73% $2.30* 252K Aug 18, 2021 Class A Common Stock 1.83K $11.50 Direct
transaction CANO Warrants to purchase Class A Common Stock Purchase $43.4K +15K +5.96% $2.89* 267K Aug 19, 2021 Class A Common Stock 15K $11.50 Direct F3
transaction CANO Warrants to purchase Class A Common Stock Purchase $13.8K +5K +1.87% $2.75* 272K Aug 20, 2021 Class A Common Stock 5K $11.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.40 to $9.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.25 to $10.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.86 to $2.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(3) to this Form 4.